Therapeutic Conflicts and Multimorbidity
NCT02928939 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1101
Last updated 2021-04-08
Summary
Clinical practice guidelines do not take into account multimorbidity and various potential therapeutic conflicts. Identifying and quantifying therapeutic conflicts is crucial in multimorbid patients having more than two acute or chronic diseases. Guidance should be available for frequent encountered situations, e.g. gastrointestinal bleeding or exacerbation of diabetes mellitus.
Conditions
- Gastrointestinal Hemorrhage
- Diabetes Complications
- Multimorbidity
Interventions
- OTHER
-
drug-drug or drug-disease interaction
Sponsors & Collaborators
-
University Hospital, Zürich
collaborator OTHER -
Center of Competence Multimorbidity, Zurich
collaborator UNKNOWN -
University of Zurich
lead OTHER
Principal Investigators
-
Edouard Battegay, Prof. MD · University Hospital Zurich, Department of Internal Medicine
-
Klarissa Siebenhüner, MD · University Hospital Zurich, Department of Internal Medicine
-
Patrick Beeler, MD · University Hospital Zurich, Department of Internal Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2020-08-31
- Completion
- 2021-04-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Mechanisms of Endothelial Dysfunction in Type 2 Diabetes
NCT02311075 ·Status: COMPLETED ·Phase: NA
-
Vascular Dysfunction in Diabetes: Genes and Hormones
NCT01511042 ·Status: TERMINATED
-
Plaque Composition in T2DM With and Without Microvascular Complications
NCT06439719 ·Status: NOT_YET_RECRUITING
-
Thyroid Dysfunction in Patients With Type 2 Diabetes With Early Diabetic Nephropathy.
NCT03154398 ·Status: COMPLETED
-
Physician-initiated Medication Review in a Type 2 Diabetes Outpatient Clinic
NCT05501223 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Intensive Multifactorial Therapy on Endothelial Function in Newly Diagnosed Type 2 Diabetes
NCT01101503 ·Status: UNKNOWN ·Phase: PHASE2
-
Diabetes Complications and the Risk of Cardiovascular and Cerebrovascular Diseases
NCT04983277 ·Status: NOT_YET_RECRUITING
-
The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients
NCT02885922 ·Status: UNKNOWN
-
Effect of a Pharmacist-led, Collaborative Practice on Clinical Outcomes in Persons with Diabetes
NCT05995262 ·Status: ACTIVE_NOT_RECRUITING
-
Erectile Dysfunction and Diabetes Mellitus
NCT00134329 ·Status: COMPLETED
-
Long-term Mortality in Diabetics Undergoing Major Surgery
NCT00286572 ·Status: COMPLETED
-
Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI
NCT04481997 ·Status: COMPLETED
-
Arginase Inhibition and Microvascular Endothelial Function in Type 2 Diabetes
NCT02687152 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Role of SGLT2I in Patients With Myocardial Infarction
NCT06245980 ·Status: UNKNOWN
-
Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease
NCT02501876 ·Status: COMPLETED
-
Metabolic Syndrome and Prediabetes
NCT07243821 ·Status: RECRUITING
-
Exercise-induced Blood Glucose Response in Patients With Type 2 Diabetes
NCT03335930 ·Status: COMPLETED ·Phase: NA
-
Development of Minimally Invasive Methodology for Diabetyping to Personalise Treatment to Realise Remission and Reversal of Type 2 Diabetes
NCT06125119 ·Status: RECRUITING
-
Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention
NCT06682351 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effect of Patient Management Based on Continuous Continuous Glucose Monitoring on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes and Moderate to Severe Coronary Artery Stenosis
NCT06060483 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Microcirculation Assessment in Diabetes and Metabolic Syndrome
NCT01014949 ·Status: COMPLETED ·Phase: NA
-
A Real World Research: Comparison of Precision and Experience Therapy for Hypertension, Diabetes or Hyperlipidemias
NCT04660630 ·Status: UNKNOWN ·Phase: NA
-
Multi-omics Mechanisms of Lifestyle Intervention in Regulating Blood Glucose
NCT07146308 ·Status: COMPLETED ·Phase: NA
-
Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients
NCT02500329 ·Status: UNKNOWN ·Phase: PHASE4
-
The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy
NCT06843304 ·Status: RECRUITING